Citadel Advisors’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-50
Closed -$1.08K 15841
2022
Q4
$1.08K Buy
+50
New +$569 ﹤0.01% 14527
2022
Q1
Sell
-4,388
Closed -$727K 14906
2021
Q4
$727K Sell
4,388
-1,775
-29% -$307K ﹤0.01% 8745
2021
Q3
$1.1M Buy
6,163
+200
+3% +$40.7K ﹤0.01% 7903
2021
Q2
$1.13M Sell
5,963
-2,137
-26% -$364K ﹤0.01% 8050
2021
Q1
$1.56M Sell
8,100
-938
-10% -$218K ﹤0.01% 7013
2020
Q4
$1.94M Buy
9,038
+2,875
+47% +$641K ﹤0.01% 5406
2020
Q3
$1.43M Buy
6,163
+2,775
+82% +$800K ﹤0.01% 5362
2020
Q2
$1.11M Buy
+3,388
New +$714K ﹤0.01% 5644

Other funds holding VAPO

Citadel Advisors's VAPO Position: Q1 2023 in Review

Citadel Advisors sold out of Vapotherm, Inc. Common Stock (VAPO) in Q1 2023, closing a stake of 1,032 shares — an estimated $22.3K sold.

Citadel Advisors first reported a position in VAPO in Q1 2020 and held it in 11 quarters. The position peaked at $6.38M in Q2 2020. 51 funds tracked by Wall St. Rank hold VAPO as of Q1 2023.

  • Citadel Advisors reported no remaining Vapotherm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,032 Vapotherm, Inc. Common Stock shares in Q1 2023, an estimated $22.3K.
  • Citadel Advisors first reported a position in Vapotherm, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Citadel Advisors's Vapotherm, Inc. Common Stock position peaked at $6.38M in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.